By 2025, enterprise capital traders are anticipated to prioritize corporations that attain part 2 and past, in line with funding service Pitchbook.
发布者:BY ANNE GRETE STORVIK,转转请注明出处:https://robotalks.cn/report-phase-2-data-will-continue-to-dominate-biotech-venture-capital-investment-in-2025/